Drug shortage: Etomidate Injection (ETOMIDATE, AMIDATE)
FDA lists 18 presentations as Current. Availability: Unavailable (4), Available (14). Reason: Other; Demand increase for the drug. Companies: Gland Pharma Limited, Hospira, Inc., a Pfizer Company, Hikma Pharmaceuticals USA, Inc., Eugia US LLC, Caplin Steriles, Ltd.….
- Published by source
- 2022-10-05
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Gland Pharma Limited
- Products
- Etomidate Injection ETOMIDATE AMIDATE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.
- Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2022-10-05
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #872 | new | 2026-10-22 | 67fa21b6fe63…4437f0 | 2a95c4f50396…5a29d8 |
Chain head: #1076 8ad5adc30b9b…88ce20